257 related articles for article (PubMed ID: 10217598)
21. Serological response of guinea pigs to oily and aqueous inactivated vaccines containing a Brazilian isolate of the Bovine Viral Diarrhea Virus (BVDV).
Jordão RS; Ribeiro CP; Pituco EM; Okuda LH; Del Fava C; Stefano Ed; Filho MM; Mehnert DU
Res Vet Sci; 2011 Oct; 91(2):311-5. PubMed ID: 21316721
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants.
Peréz Aguirreburualde MS; Gómez MC; Ostachuk A; Wolman F; Albanesi G; Pecora A; Odeon A; Ardila F; Escribano JM; Dus Santos MJ; Wigdorovitz A
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):315-24. PubMed ID: 23291101
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of experimental vaccines for bovine viral diarrhea in bovines, ovines and guinea pigs.
Fernández F; Costantini V; Barrandeguy M; Parreño V; Schiappacassi G; Maliandi F; Leunda M; Odeón A
Rev Argent Microbiol; 2009; 41(2):86-91. PubMed ID: 19623897
[TBL] [Abstract][Full Text] [Related]
24. The bovine viral diarrhea virus E2 protein formulated with a novel adjuvant induces strong, balanced immune responses and provides protection from viral challenge in cattle.
Snider M; Garg R; Brownlie R; van den Hurk JV; van Drunen Littel-van den Hurk S
Vaccine; 2014 Nov; 32(50):6758-64. PubMed ID: 25454860
[TBL] [Abstract][Full Text] [Related]
25. Fetal protection against bovine viral diarrhoea type 1 virus infection after one administration of a live-attenuated vaccine.
Meyer G; Deplanche M; Roux D; Moulignie M; Picard-Hagen N; Lyazrhi F; Raboisson D; Mathevet P; Schelcher F
Vet J; 2012 May; 192(2):242-5. PubMed ID: 21689959
[TBL] [Abstract][Full Text] [Related]
26. Protective effects against abortion and fetal infection following exposure to bovine viral diarrhea virus and bovine herpesvirus 1 during pregnancy in beef heifers that received two doses of a multivalent modified-live virus vaccine prior to breeding.
Givens MD; Marley MS; Jones CA; Ensley DT; Galik PK; Zhang Y; Riddell KP; Joiner KS; Brodersen BW; Rodning SP
J Am Vet Med Assoc; 2012 Aug; 241(4):484-95. PubMed ID: 22852575
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of an E2 glycoprotein subunit vaccine produced in mammalian cells to prevent experimental infection with bovine viral diarrhoea virus in cattle.
Pecora A; Aguirreburualde MS; Aguirreburualde A; Leunda MR; Odeon A; Chiavenna S; Bochoeyer D; Spitteler M; Filippi JL; Dus Santos MJ; Levy SM; Wigdorovitz A
Vet Res Commun; 2012 Sep; 36(3):157-64. PubMed ID: 22639081
[TBL] [Abstract][Full Text] [Related]
28. Immunocompetent truncated E2 glycoprotein of bovine viral diarrhea virus (BVDV) expressed in Nicotiana tabacum plants: a candidate antigen for new generation of veterinary vaccines.
Nelson G; Marconi P; Periolo O; La Torre J; Alvarez MA
Vaccine; 2012 Jun; 30(30):4499-504. PubMed ID: 22554468
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of four commercially available multivalent modified-live virus vaccines against clinical disease, viremia, and viral shedding in early-weaned beef calves exposed simultaneously to cattle persistently infected with bovine viral diarrhea virus and cattle acutely infected with bovine herpesvirus 1.
Chamorro MF; Walz PH; Passler T; Palomares R; Newcomer BW; Riddell KP; Gard J; Zhang Y; Galik P
Am J Vet Res; 2016 Jan; 77(1):88-97. PubMed ID: 26709942
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of long-term antibody responses to two inactivated bovine viral diarrhoea virus (BVDV) vaccines.
González AM; Arnaiz I; Yus E; Eiras C; Sanjuán M; Diéguez FJ
Vet J; 2014 Mar; 199(3):424-8. PubMed ID: 24461201
[TBL] [Abstract][Full Text] [Related]
31. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
Cortese VS; Grooms DL; Ellis J; Bolin SR; Ridpath JF; Brock KV
Am J Vet Res; 1998 Nov; 59(11):1409-13. PubMed ID: 9829398
[TBL] [Abstract][Full Text] [Related]
32. Prevention of transplacental infection of bovine foetus by bovine viral diarrhoea virus through vaccination.
Patel JR; Shilleto RW; Williams J; Alexander DC
Arch Virol; 2002 Dec; 147(12):2453-63. PubMed ID: 12491111
[TBL] [Abstract][Full Text] [Related]
33. Construction of chimeric bovine viral diarrhea viruses containing glycoprotein E rns of heterologous pestiviruses and evaluation of the chimeras as potential marker vaccines against BVDV.
Luo Y; Yuan Y; Ankenbauer RG; Nelson LD; Witte SB; Jackson JA; Welch SK
Vaccine; 2012 Jun; 30(26):3843-8. PubMed ID: 22521286
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity of an inactivated Chinese bovine viral diarrhea virus 1a (BVDV 1a) vaccine cross protects from BVDV 1b infection in young calves.
Wang W; Shi X; Wu Y; Li X; Ji Y; Meng Q; Zhang S; Wu H
Vet Immunol Immunopathol; 2014 Aug; 160(3-4):288-92. PubMed ID: 24880701
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of multiple immune parameters after vaccination with modified live or killed bovine viral diarrhea virus vaccines.
Reber AJ; Tanner M; Okinaga T; Woolums AR; Williams S; Ensley DT; Hurley DJ
Comp Immunol Microbiol Infect Dis; 2006 Jan; 29(1):61-77. PubMed ID: 16543046
[TBL] [Abstract][Full Text] [Related]
36. Development of a fetal challenge method for the evaluation of bovine viral diarrhea virus vaccines.
Brock KV; Chase CC
Vet Microbiol; 2000 Nov; 77(1-2):209-14. PubMed ID: 11042414
[TBL] [Abstract][Full Text] [Related]
37. Foetal protection against bovine virus diarrhoea virus after two-step vaccination.
Frey HR; Eicken K; Grummer B; Kenklies S; Oguzoglu TC; Moennig V
J Vet Med B Infect Dis Vet Public Health; 2002 Dec; 49(10):489-93. PubMed ID: 12485359
[TBL] [Abstract][Full Text] [Related]
38. Enhanced neutralising antibody response to bovine viral diarrhoea virus (BVDV) induced by DNA vaccination in calves.
R El-Attar LM; Thomas C; Luke J; A Williams J; Brownlie J
Vaccine; 2015 Jul; 33(32):4004-12. PubMed ID: 26079613
[TBL] [Abstract][Full Text] [Related]
39. Mosaic Bovine Viral Diarrhea Virus Antigens Elicit Cross-Protective Immunity in Calves.
Sangewar N; Hassan W; Lokhandwala S; Bray J; Reith R; Markland M; Sang H; Yao J; Fritz B; Waghela SD; Abdelsalam KW; Chase CCL; Mwangi W
Front Immunol; 2020; 11():589537. PubMed ID: 33281819
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of an ELISA for quantitation of bovine viral diarrhea virus antigen in the critical stages of vaccine production.
Pecora A; Perez Aguirreburualde MS; Ostachuk A; Rodriguez D; Seki C; Levy MS; Bochoeyer D; Dus Santos MJ; Wigdorovitz A
J Virol Methods; 2009 Dec; 162(1-2):170-8. PubMed ID: 19665482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
